Skip to content

Changes from 1 March 2022: Dexcom


From 1 March 2022, the Dexcom G5 Mobile CGM system (Dexcom G5 Mobile sensor and transmitter products) will be removed from the range of devices available through the NDSS.

To coincide with the delisting of Dexcom G5, from 1 March 2022, the Dexcom G6 CGM system will be available through the NDSS to all people who meet the eligibility criteria. Read more.

Diabetes Australia acknowledges Aboriginal and Torres Strait Islander peoples as the Traditional Owners and Custodians of this Country. We recognise their connection to land, waters, winds and culture. We pay the upmost respect to them, their cultures and to their Elders, past and present. We are committed to improving health outcomes for all Aboriginal and Torres Strait Islander people affected by diabetes and those at risk.

Learn about the artwork